Implementation and evaluation of shared decision-making for breast cancer follow-up care

Recruiting

• Conditions: Breast cancer

• Registration Number: NL-OMON22492
• Lead Sponsor: Santeon

Brief Summary

.A.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 630

Inclusion Criteria

1) Patients must be facing the decision for the organisation of follow-up care after receiving curative treatment for invasive breast cancer (in the first follow-up consultation about 1 year after surgery); 2) Being treated in a Santeon hospital; 3) = 18 years of age; 4) Understand the Dutch language in speech and writing, and; 5) Able to provide informed consent.

Exclusion Criteria

1) Patients diagnosed with non-invasive breast cancer (e.g. Ductal Carcinoma In Situ (DCIS)); 2) Patients who receive palliative treatment; 3) Patients who received neoadjuvant therapy; 4) Male breast cancer patients; 5) Patients with dementia; 6) Patients who received treatment for a recurrence or second primary tumor; 7) Patients with a breast cancer-related gene alteration (e.g. BRCA).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients' perceived level of involvement in the decision-making process (using the SDM-Q-9).

Secondary Outcome Measures

Name	Time	Method
Patients' involvement in the decision-making process from the observers' viewpoint (using the OPTION-5).